Andrea R.
- Country
- Italy
- Department
- S.C. Nefrologia - Clinica Nefrologica
Research Overview
- Frexalimab Versus Tacrolimus for Prevention of Kidney Graft Rejection in Adult Kidney Transplant Recipients
- Evaluation of Ravulizumab Efficacy and Safety in Adult Patients with Immunoglobulin A Nephropathy: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Corticosteroids, Dapagliflozin, and RASBs on Proteinuria in IgA Nephropathy Patients with Active and Chronic Renal Lesions
Data & Insights
Has run more than one trial at 27 of 156 partner sites.
Specializations
Nephrology Focus
This investigator specializes in Immunoglobulin A Nephropathy (IgAN), conducting comprehensive research into treatment approaches for this kidney condition. Their work encompasses evaluation of various therapeutic interventions for managing proteinuria and preserving renal function.
- IgA Nephropathy Management
- Kidney Function Preservation
- Proteinuria Treatment
Therapeutic Approaches
The investigator explores multiple treatment modalities including targeted therapy based on kidney biopsy findings and early corticosteroid therapy. Their research extends to evaluating novel therapeutic agents such as SGLT2 inhibitors and specialized antibody treatments.
- Biopsy-Guided Treatment
- Corticosteroid Therapy
- Novel Therapeutic Agents
Clinical Expertise
Their clinical focus includes investigation of renal lesions in IgAN patients, encompassing both active and chronic manifestations. The investigator evaluates various treatment combinations including RAS blockers and targeted therapeutic approaches.
- Renal Pathology
- Treatment Optimization
- Disease Progression Management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.